Evidence-gap map · non-drug interventions

Irritable Bowel Syndrome evidence gaps

382 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Irritable Bowel Syndrome

Which non-drug approaches have been tested for Irritable Bowel Syndrome, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

382registered non-drug trials
18with results posted
44recruiting as of 2026-11-16
87group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Irritable Bowel Syndrome by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (17)1··22·31 with results··521 with results414·11
Rehabilitation and therapy services (2)···1····11··2···
Breathing and respiratory training (4)···11111····3···
Mind-body and psychological approaches (66)1·161 with results10111·12·81 with results404 with results176
Cognitive training and education (18)1··42····91 with results·1111 with results·2·
Diet, fasting and nutrition (93)1··2131 with results·1··14312671 with results1291 with results
Sleep and circadian approaches (1)············1···
Neuromodulation and electrical stimulation (17)21 with results·1341·11 with results11 with results3·22 with results121 with results·21
Oxygen, light, temperature and manual therapies (17)···13·2··1··11114
Supplements and nutraceuticals (156)···7311 with results12··12420913 with results·4272 with results
Other devices and digital tools (1)·········1······
Care delivery and health services (1)·········1··1···
Other behavioural, not yet classified (20)1··361···4·29·31 with results1

The table scrolls sideways: 16 outcome columns.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (43 trials of other approaches did).
  • Among the 66 trials of mind-body and psychological approaches found, none used weight and metabolic markers as a primary outcome (8 trials of other approaches did).
  • Among the 18 trials of cognitive training and education found, none used weight and metabolic markers as a primary outcome (8 trials of other approaches did).
  • Among the 17 trials of neuromodulation and electrical stimulation found, none used weight and metabolic markers as a primary outcome (8 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used weight and metabolic markers as a primary outcome (8 trials of other approaches did).
  • Among the 18 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
  • Among the 17 trials of neuromodulation and electrical stimulation found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
  • Among the 156 trials of supplements and nutraceuticals found, none used fatigue and energy as a primary outcome (5 trials of other approaches did).
  • Among the 93 trials of diet, fasting and nutrition found, none used sleep as a primary outcome (5 trials of other approaches did).
  • Among the 18 trials of cognitive training and education found, none used sleep as a primary outcome (5 trials of other approaches did).
  • Among the 17 trials of exercise and physical activity found, none used sleep as a primary outcome (5 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used fatigue and energy as a primary outcome (5 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used sleep as a primary outcome (5 trials of other approaches did).
  • Among the 156 trials of supplements and nutraceuticals found, none used heart rate, blood pressure and autonomic as a primary outcome (3 trials of other approaches did).

Questions studied but with no results posted

  • Supplements and nutraceuticals × inflammation and other biomarkers: 20 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × symptom severity and disease activity: 14 trials registered, none with results posted (2 still recruiting)
  • Diet, fasting and nutrition × quality of life: 14 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × quality of life: 12 trials registered, none with results posted (1 still recruiting)
  • Diet, fasting and nutrition × inflammation and other biomarkers: 12 trials registered, none with results posted (1 still recruiting)
  • Supplements and nutraceuticals × quality of life: 12 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 11 trials registered, none with results posted (2 still recruiting)
  • Mind-body and psychological approaches × pain: 10 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × feasibility, adherence and safety: 7 trials registered, none with results posted (1 still recruiting)
  • Supplements and nutraceuticals × mood, anxiety and wellbeing: 7 trials registered, none with results posted
  • Exercise and physical activity × quality of life: 5 trials registered, none with results posted
  • Exercise and physical activity × inflammation and other biomarkers: 4 trials registered, none with results posted
  • Cognitive training and education × mood, anxiety and wellbeing: 4 trials registered, none with results posted
  • Neuromodulation and electrical stimulation × pain: 4 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Irritable Bowel Syndrome

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 47 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.